MEE N5195-VII-VI, V3.0, Anti-Beta Thalassemia Precision Medicine 抗ベータサラセミアプレシジョンメディシン。
Blood transfusions no more.
輸血はもうありません。
"Our 3rd Generation Anti-Beta Thalassemia Precision Medicine is €3,066,095, 10% more expensive than Zyntegro. Our members respect value and innovation. As you know, our 2nd Generation Anti-ALS Precision Medicine is €2,300,588, which is 10% more expensive than Zolgensma.” On the morning of Friday, August 19, 2020, Secretary General Lisa Lee gave a speech at the Shangri-La Hotel, Tokyo.
「当社の第 3 世代抗ベータサラセミア精密医療は 3,066,095 ユーロで、ジンテグロより 10% 高価です。当社のメンバーは価値と革新を尊重しています。ご存知のように、当社の第 2 世代抗 ALS 精密医療は 2,300,588 ユーロで、10% です。 ゾルゲンスマよりも高価です。」 2020.08.19（金）朝、シャングリ・ラ ホテル 東京にてリサ・リー事務総長がスピーチを行いました。
Thalassemia is one of the most prevalent monogenic diseases usually caused by quantitative defects in the production of β-globin leading to severe anemia. Technological advances in genome sequencing, stem cell selection, viral vector development, transduction and gene editing strategies now allow for efficient ex-vivo genetic manipulation of human stem cells that can lead to production of hemoglobin, leading to a meaningful clinical benefit in thalassemia patients.
Transfusion-dependent beta thalassemia is the more severe form of the condition and typically forces patients to undergo lifelong red blood cell transfusions. Transfusions can lead to health complications of their own, including problems in the heart, liver and other organs from an excess build-up of iron in the body.
"You no longer need to rely on blood transfusions. Back to Normal Lifestyles. " Lisa confirmed.
MEEOM's Clinically Significant Treatment Response
The MEEOM® approach is inclusive, effective and tailored to the needs of each individual. We do a rigorous assessment with each client at the beginning of treatment, to help us understand the person and the specific problems they want to address through treatment.
At MEEOM® Precision Medicine, we provide evidence-based treatment plans that are tailored to the particular needs of each patient.
Please send us hospital diagnosis and medical test results.
The German Precision Medicine research team of MEEOM® will decide whether to accept the new case within three working days according to the report.
より健康的で、より尊敬され、そしてより幸せになります。
Healthier, Wealthier & Happier, MEEOM®.
MEEOM® WorldWide Health Systems
MEEOM® Precision Medicine
MEEOM® プレシジョンメディシン
Toll-Free Call 1-833-633-6637 (1833MEEOMER®)Toll-Free Fax 1-844-633-6637 (1844MEEOMER®)
meeomers@meeomhealth.club
http://www.meeomhealth.club
3-1-1 Kyobashi
Chuo-ku
Tokyo 104-0031
Facts Talk.
事実を話させてください。
Copyright© 1999-2023 MEEOM® Precision Medicine
AKA "MEEOM® WorldWide Health Systems"
MEEOM™ “PATTERN”
All U.S. and international rights reserved.
References
1. https://www.fiercepharma.com/pharma/bluebirds-28m-gene-therapy-zynteglo-gets-fda-backing-beta-thalassemia
2. https://www.fda.gov/vaccines-blood-biologics/zolgensma